Chamaria announced her appointment on LinkedIn. She is returning to consumer health after more than 23 years across marketing, business strategy and brand building.
Haleon identifies Oral Health as one of its six key consumer-health categories, giving the business a distinct place in the company's portfolio alongside areas such as pain relief, respiratory health and digestive health.
A cross-sector leadership background
Before joining Haleon, Chamaria was Chief Marketing Officer at Blue Tokai Coffee Roasters. She previously held roles at Google, Yum! Brands and GlaxoSmithKline Consumer Healthcare, among others.
That experience spans categories with different customer needs and business models. It also puts marketing and business strategy at the centre of her new remit, rather than tying the role to one product category.
Haleon's regional hiring activity also includes a Dental Detailing Representative role linked to its oral-health portfolio and a Net Revenue Manager position in Karachi, indicating continuing commercial activity across South Asia. No separate official press release or regulatory filing confirming Chamaria's appointment was identified in the reviewed material.
Returning to consumer health
"There's something quite special and exciting about coming back to Consumer Health, where I spent several early years of my career - this time in a very different role and with a very different perspective to bring to the table," she said.
Leadership roles in oral health and related organisations have also drawn attention. One example is the recent sector appointment of Andrew Hay as chief executive of the Oral Health Foundation from January 2027.
Haleon's corporate disclosures treat oral health as a standalone business category. In a separate regional development, industry coverage has reported stronger oral-health leadership in Latin America. That points to management attention to the category in more than one geography.
The numbers need context. Market commentary on Haleon cited 2.6% organic growth in the first half of 2026. The same commentary reported a 4.7% decline in respiratory health over that period. These figures came from a community market narrative, not a direct company announcement.
That comparison offers context on the different performance of Haleon's categories. The available announcement does not set out Chamaria's operational priorities or describe changes to Haleon's portfolio.
It does establish a senior appointment built around marketing, strategy and brand development. The role remains undefined beyond that.
For the oral health industry, Chamaria brings commercial experience back to consumer health. Her cross-category background gives the South Asia role a wider perspective, even though Haleon has not yet detailed the agenda she will pursue.
